A detailed history of Great West Life Assurance CO transactions in Haemonetics Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 46,474 shares of HAE stock, worth $3.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,474
Previous 50,728 8.39%
Holding current value
$3.47 Million
Previous $4.33 Million 11.15%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$81.24 - $97.37 $345,594 - $414,211
-4,254 Reduced 8.39%
46,474 $3.85 Million
Q1 2024

May 13, 2024

BUY
$71.24 - $85.35 $422,666 - $506,381
5,933 Added 13.24%
50,728 $4.33 Million
Q4 2023

Feb 13, 2024

BUY
$80.59 - $92.61 $386,429 - $444,064
4,795 Added 11.99%
44,795 $3.82 Million
Q3 2023

Nov 14, 2023

BUY
$82.56 - $93.49 $257,339 - $291,408
3,117 Added 8.45%
40,000 $3.58 Million
Q2 2023

Aug 10, 2023

SELL
$80.84 - $89.45 $291,589 - $322,646
-3,607 Reduced 8.91%
36,883 $3.14 Million
Q1 2023

May 12, 2023

SELL
$72.75 - $90.6 $83,226 - $103,646
-1,144 Reduced 2.75%
40,490 $3.35 Million
Q4 2022

Feb 10, 2023

BUY
$73.85 - $86.14 $475,003 - $554,052
6,432 Added 18.27%
41,634 $3.28 Million
Q3 2022

Nov 01, 2022

BUY
$63.3 - $78.66 $251,870 - $312,988
3,979 Added 12.74%
35,202 $2.61 Million
Q2 2022

Aug 12, 2022

BUY
$49.27 - $66.08 $1.54 Million - $2.06 Million
31,223 New
31,223 $2.03 Million
Q2 2022

Aug 09, 2022

SELL
$49.27 - $66.08 $1.37 Million - $1.84 Million
-27,886 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$43.77 - $63.22 $88,327 - $127,577
2,018 Added 7.8%
27,886 $1.81 Million
Q4 2021

Feb 14, 2022

BUY
$49.55 - $74.59 $96,424 - $145,152
1,946 Added 8.13%
25,868 $1.37 Million
Q3 2021

Nov 15, 2021

BUY
$57.6 - $70.59 $266,054 - $326,055
4,619 Added 23.93%
23,922 $1.7 Million
Q2 2021

Aug 11, 2021

SELL
$51.81 - $118.56 $20,931 - $47,898
-404 Reduced 2.05%
19,303 $1.29 Million
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $170,400 - $214,101
-1,535 Reduced 7.23%
19,707 $2.19 Million
Q4 2020

Feb 16, 2021

SELL
$88.75 - $119.95 $231,193 - $312,469
-2,605 Reduced 10.92%
21,242 $2.52 Million
Q3 2020

Nov 17, 2020

SELL
$75.65 - $93.58 $7.97 Million - $9.86 Million
-105,360 Reduced 81.54%
23,847 $2.08 Million
Q3 2020

Nov 13, 2020

BUY
$75.65 - $93.58 $7.86 Million - $9.72 Million
103,899 Added 410.54%
129,207 $11.3 Million
Q2 2020

Aug 17, 2020

SELL
$84.96 - $118.91 $94,985 - $132,941
-1,118 Reduced 4.23%
25,308 $2.27 Million
Q1 2020

May 14, 2020

BUY
$74.34 - $121.82 $138,421 - $226,828
1,862 Added 7.58%
26,426 $2.63 Million
Q4 2019

Feb 11, 2020

BUY
$114.37 - $129.46 $2.81 Million - $3.18 Million
24,564 New
24,564 $2.82 Million
Q3 2019

Oct 25, 2019

SELL
$117.16 - $138.52 $3.45 Million - $4.08 Million
-29,453 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$81.74 - $120.34 $184,650 - $271,848
-2,259 Reduced 7.12%
29,453 $0
Q1 2019

May 08, 2019

SELL
$83.25 - $102.12 $15,651 - $19,198
-188 Reduced 0.59%
31,712 $2.77 Million
Q4 2018

Feb 12, 2019

BUY
$90.66 - $116.63 $164,275 - $211,333
1,812 Added 6.02%
31,900 $2.96 Million
Q3 2018

Nov 13, 2018

SELL
$89.96 - $114.58 $65,850 - $83,872
-732 Reduced 2.38%
30,088 $3.45 Million
Q2 2018

Aug 10, 2018

SELL
$71.53 - $95.75 $2.82 Million - $3.78 Million
-39,471 Reduced 56.15%
30,820 $2.76 Million
Q1 2018

May 10, 2018

BUY
$60.72 - $74.41 $97,759 - $119,800
1,610 Added 2.34%
70,291 $5.14 Million
Q4 2017

Feb 09, 2018

SELL
$44.96 - $58.99 $157,719 - $206,936
-3,508 Reduced 4.86%
68,681 $3.99 Million
Q3 2017

Nov 09, 2017

BUY
$40.38 - $44.87 $2.91 Million - $3.24 Million
72,189
72,189 $3.12 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.83B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.